Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
9.31
+0.67 (7.75%)
At close: May 29, 2026, 4:00 PM EDT
9.49
+0.18 (1.93%)
After-hours: May 29, 2026, 5:22 PM EDT
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
102
Market Cap
97.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 24.99M | 15.26M | 156.83% |
| Dec 31, 2021 | 9.73M | -8.17M | -45.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fortress Biotech | 66.16M |
| ImmuCell | 29.93M |
| Pelthos Therapeutics | 27.70M |
| MindWalk Holdings | 20.70M |
| Outlook Therapeutics | 333.14K |
ACET News
- 15 days ago - Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 16 days ago - Adicet Bio reports Q1 EPS ($1.88), consensus ($3.08) - TheFly
- 16 days ago - Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates - Business Wire
- 16 days ago - Adicet Bio Earnings release: Q1 2026 - Filings
- 16 days ago - Adicet Bio Quarterly report: Q1 2026 - Filings
- 16 days ago - Adicet Bio Slides: Investor presentation - Filings
- 25 days ago - Adicet Bio assumed with a Buy at Jefferies - TheFly
- 4 weeks ago - Adicet Bio Proxy statement: Proxy filing - Filings